The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?
Clinical Microbiology and Infection · 2026-05 · 32 (5) · 706-714
DOI: 10.1016/j.cmi.2025.10.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2026-05. Verfasst von Anna Apostolopoulou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY, USA. Electroni…. Hauptthemen laut MEDLINE: Immunocompromised Host, Invasive Fungal Infections, Fungi. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 133 Literaturangaben. Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Merck.
Abstract (Originalsprache)
BACKGROUND: The epidemiology of invasive mould diseases in immunocompromised hosts is evolving due to a combination of environmental and host-related factors. OBJECTIVES: Our goal is to characterize this changing epidemiology by exploring two key aspects: (a) the evolution of moulds and (b) the expansion of the pool of immunocompromised hosts in the current era. SOURCES: We searched PubMed and Google Scholar with the combination of the following keywords: "fungal epidemiology", "mold OR mould", "environment", "invasive fungal infection", "invasive mold infection", "Mucor∗", "Aspergill∗", "Fusari∗", "Scedospor∗", "antifungal resistance", "immunocompromised hosts". We also searched the reference lists of all relevant publications for additional references. CONTENT: We describe the changing spectrum of invasive mould infections in the context of emerging antifungal resistance and the rapidly evolving landscape of immunocompromised patient populations. IMPLICATIONS: Recognition of fungal adaptation to environmental changes and the spectrum of immunocompromised hosts is critical for timely diagnosis and management of invasive mould infections, health policy, and research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY, USA. Electronic address: ana4036@med.cornell.edu.
- Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
- Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Merck
Zitieren
APA
Apostolopoulou, A., Kampouri, E., & Little, J. S. (2026). The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?. Clinical Microbiology and Infection, 32(5), 706-714. https://doi.org/10.1016/j.cmi.2025.10.021
Vancouver
Apostolopoulou A, Kampouri E, Little JS. The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?. Clinical Microbiology and Infection. 2026;32(5):706-714. doi:10.1016/j.cmi.2025.10.021
BibTeX
@article{Apostolopoulou2026,
author = {Apostolopoulou, Anna and Kampouri, Eleftheria and Little, Jessica S},
title = {The changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?},
journal = {Clinical Microbiology and Infection},
year = {2026},
volume = {32},
number = {5},
pages = {706--714},
doi = {10.1016/j.cmi.2025.10.021}
}
EUVIMED